A detailed history of Jane Street Group, LLC transactions in Landec Corp \Ca\ stock. As of the latest transaction made, Jane Street Group, LLC holds 36,246 shares of LNDC stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,246
Previous 17,969 101.71%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
N/A
18,277 Added 101.71%
36,246 $0
Q2 2024

Aug 14, 2024

SELL
N/A
-277,618 Reduced 93.92%
17,969 $0
Q1 2024

May 15, 2024

BUY
N/A
159,357 Added 116.98%
295,587 $0
Q4 2023

Feb 14, 2024

BUY
N/A
100,851 Added 285.06%
136,230 $0
Q3 2023

Nov 14, 2023

SELL
N/A
-59,571 Reduced 62.74%
35,379 $0
Q2 2023

Aug 14, 2023

BUY
N/A
94,950 New
94,950 $0
Q3 2021

Nov 16, 2021

SELL
$9.22 - $12.44 $135,985 - $183,477
-14,749 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$9.91 - $12.78 $146,162 - $188,492
14,749 New
14,749 $166,000

Others Institutions Holding LNDC

About LANDEC CORP \CA\


  • Ticker LNDC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,595,600
  • Description
  • Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...
More about LNDC
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.